NZ182865A - 2.9 -dichloro-6 -fluoro-16 -methyl-11 ,17 , 21-trihydroxy-pregna-1,4-diene-3,20-diones - Google Patents

2.9 -dichloro-6 -fluoro-16 -methyl-11 ,17 , 21-trihydroxy-pregna-1,4-diene-3,20-diones

Info

Publication number
NZ182865A
NZ182865A NZ182865A NZ18286576A NZ182865A NZ 182865 A NZ182865 A NZ 182865A NZ 182865 A NZ182865 A NZ 182865A NZ 18286576 A NZ18286576 A NZ 18286576A NZ 182865 A NZ182865 A NZ 182865A
Authority
NZ
New Zealand
Prior art keywords
pregna
diones
trihydroxy
dichloro
diene
Prior art date
Application number
NZ182865A
Other languages
English (en)
Inventor
C Meystre
G Anner
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NZ182865A publication Critical patent/NZ182865A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
NZ182865A 1975-12-12 1976-12-10 2.9 -dichloro-6 -fluoro-16 -methyl-11 ,17 , 21-trihydroxy-pregna-1,4-diene-3,20-diones NZ182865A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1615075A CH626632A5 (en) 1975-12-12 1975-12-12 Process for the preparation of halopregnadienes

Publications (1)

Publication Number Publication Date
NZ182865A true NZ182865A (en) 1979-06-08

Family

ID=4414834

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ182865A NZ182865A (en) 1975-12-12 1976-12-10 2.9 -dichloro-6 -fluoro-16 -methyl-11 ,17 , 21-trihydroxy-pregna-1,4-diene-3,20-diones

Country Status (19)

Country Link
JP (1) JPS5273852A (xx)
AT (1) AT353432B (xx)
AU (1) AU510864B2 (xx)
BE (1) BE849267A (xx)
CA (1) CA1078824A (xx)
CH (2) CH626632A5 (xx)
DD (1) DD128682A5 (xx)
DE (1) DE2655802A1 (xx)
DK (1) DK142326B (xx)
ES (2) ES454119A1 (xx)
FR (1) FR2358152A1 (xx)
GB (1) GB1563595A (xx)
HU (1) HU176936B (xx)
IE (1) IE44512B1 (xx)
IL (1) IL51085A (xx)
NL (1) NL7613711A (xx)
NZ (1) NZ182865A (xx)
SE (1) SE7613919L (xx)
ZA (1) ZA767381B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT78973A (en) * 1984-07-25 1984-08-01 Joao Emerico Villax New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid

Also Published As

Publication number Publication date
DK557576A (xx) 1977-06-13
GB1563595A (en) 1980-03-26
SE7613919L (sv) 1977-06-13
ZA767381B (en) 1977-11-30
FR2358152B1 (xx) 1982-10-22
AU510864B2 (en) 1980-07-17
AT353432B (de) 1979-11-12
NL7613711A (nl) 1977-06-14
DK142326B (da) 1980-10-13
JPS5273852A (en) 1977-06-21
IL51085A0 (en) 1977-02-28
DK142326C (xx) 1981-03-09
AU2047176A (en) 1978-06-15
CA1078824A (en) 1980-06-03
CH626632A5 (en) 1981-11-30
HU176936B (hu) 1981-06-28
IE44512L (en) 1977-06-12
ES465551A1 (es) 1978-09-16
CH626094A5 (en) 1981-10-30
FR2358152A1 (fr) 1978-02-10
IL51085A (en) 1980-09-16
BE849267A (fr) 1977-06-10
ES454119A1 (es) 1978-03-01
IE44512B1 (en) 1981-12-30
ATA914176A (de) 1979-04-15
DD128682A5 (de) 1977-12-07
DE2655802A1 (de) 1977-06-16

Similar Documents

Publication Publication Date Title
PH20254A (en) 1,2 dihydro-2-oxo-(pyridiny,) nicotinanide
NZ181619A (en) 1-aminoalkoxy-4-substituted-1 2, 3, 4-tetrahydroiso-quinolines
AU508224B2 (en) 9 21-dihalogeno-11 17 -dihydroxy-6 -fluro-16-methyl-pregna-1,4-diene-3,20-diones
NZ181482A (en) Androsta-4 , 16-dien-3-ones
AU1622176A (en) 4,5-dihydro-2-lower-alkoxycarbonyl-amino-4 phenylimidazoles
AU498333B2 (en) 7-substituted-benzo-1, 2, 4-triazine-3-ethers
GB1520958A (en) 11-deoxy-16-aryl - 17,18,19,20 - tetranorprostaglandins
AU2043676A (en) 1, 4-diphenyl-3-pyrazolin-5-ones
GB1532697A (en) 2,3-dihydroergolines
GB1557694A (en) 2,9 dichlorquinacridone
PH14168A (en) 2,4-pyrrolidinediones
AU1214076A (en) 2,3-dihalogen-alkanoyl-ureas
GB1554021A (en) 4,5-didehydroprostaglandins
GB1483330A (en) 2,5-dimethoxy-4-chloroaniline
AU3079477A (en) 15, 15-dihydroxyprostaglandins
AU513758B2 (en) 2, 2-dimethyl 19-nor steroids
NZ182865A (en) 2.9 -dichloro-6 -fluoro-16 -methyl-11 ,17 , 21-trihydroxy-pregna-1,4-diene-3,20-diones
GB1536691A (en) 16-methyl-17-bromo-1,4-pregnadien-21-ol-3,20-dione compounds
GB1554925A (en) 2,3-methyl-eneprostaglandins
GB1518864A (en) Novel 2,2-dimethyl steroids
AU1483576A (en) 16,16-dimethyl-prostaglandins
AU1724576A (en) 2,4-diamino-5-benzylpyrimidines
PH16286A (en) 1,2-dihydro-6-phenyl-1h,4h-imidazo-benzodiazepin-1-ones
AU2744877A (en) 21,21-dihalo steroids
NZ182356A (en) D-homopregna-1,4-diene -3,ii,20-triones